Bris­tol My­ers ex­pands foot­print in In­dia with drug de­vel­op­ment and IT cen­ter

Phar­ma gi­ant Bris­tol My­ers Squibb will ex­pand its foot­print in Hy­der­abad, In­dia, with a life sci­ences hub that will fo­cus on IT and drug de­vel­op­ment. It’s ex­pect­ed to be op­er­a­tional by the mid­dle of 2023.

The com­pa­ny will in­vest about $100 mil­lion in­to the cen­ter and will em­ploy around 1,500 peo­ple, ac­cord­ing to lo­cal news sites. The ex­act lo­ca­tion of the cen­ter in the re­gion is un­known.

“We an­tic­i­pate that the full de­vel­op­ment of this site will take place over the next few years,” a BMS spokesper­son told End­points News. “We are still in the ear­ly phas­es of plan­ning but are con­fi­dent this ex­pan­sion will fur­ther po­si­tion BMS’s ef­forts to ac­cel­er­ate drug de­vel­op­ment, bol­ster in­ter­nal dig­i­tal in­no­va­tion ca­pac­i­ty and ad­vance our com­mit­ment to be­ing a more glob­al com­pa­ny.”

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

Life Sciences Senior Associate

General Catalyst

San Francisco, CA, USA